Kiyohide Nunoi

Affiliations

Department of Diabetes and Endocrinology, St Mary's Hospital, Fukuoka, Japan.

ORCID: 0000-0002-3475-7437

Publications (3)

Basal insulin secretion capacity predicts the initial response and maximum levels of beta-hydroxybutyrate during therapy with the sodium-glucose co-transporter-2 inhibitor tofogliflozin, in relation to weight loss.

Diabetes, obesity & metabolism

Avec: Yuichi Sato , Kiyohide Nunoi , Kohei Kaku , Akihiro Yoshida , Hideki Suganami

Development of the Daily Time Management Scale for Use by Working People with Type 2 Diabetes.

Japan journal of nursing science : JJNS

Avec: Tomomi Nakao , Chizuko Takeishi , Kiyohide Nunoi , Toyojiro Matsuishi , Hisayoshi Okamura , Yuichi Sato , Yuji Uchizono , Mika Mizuno , Yumi Yokobori , Yasuko Shimizu

Renal effects of a sodium-glucose cotransporter 2 inhibitor, tofogliflozin, in relation to sodium intake and glycaemic status.

Diabetes, obesity & metabolism

Avec: Kiyohide Nunoi , Yuichi Sato , Kohei Kaku , Akihiro Yoshida , Hideki Suganami

Réseau de co-auteurs

Yuichi Sato 3 collaborations

Kohei Kaku 2 collaborations

Akihiro Yoshida 2 collaborations

Hideki Suganami 2 collaborations

Tomomi Nakao 1 collaboration

Chizuko Takeishi 1 collaboration

Toyojiro Matsuishi 1 collaboration

Hisayoshi Okamura 1 collaboration

Yuji Uchizono 1 collaboration

Mika Mizuno 1 collaboration

Yumi Yokobori 1 collaboration

Yasuko Shimizu 1 collaboration